肾脏与胃肠道疾病交叉点:核心课程2026
该核心课程以病例为基础,阐述肠-肾轴的双向交互:肠道菌群改变可促进CKD进展,尿毒症毒素可损害肠道健康。文章还探讨肠促胰素尤其是GLP-1在肠-肾信号中的作用,以及胃肠道疾病与IgA肾病、炎症性肠病肾脏表现的联系,并综述CKD和终末期肾病增加胃肠道疾病风险及影响管理。
要点
- 肠-肾轴是双向系统,肠道菌群改变与CKD进展相关
- 尿毒症毒素可对肠道健康产生不良影响
- GLP-1等肠促胰素在肠-肾信号中起重要作用
核心结论
- 肾脏与胃肠道通过肠-肾轴双向系统紧密相连,CKD与胃肠道疾病相互影响并增加管理复杂性。
研究设计与样本
- AJKD核心课程,采用基于病例的格式阐述肾脏与胃肠道的复杂交互。
主要发现
- 肠道菌群改变可促进CKD进展,晚期肾功能不全产生的尿毒症毒素可对肠道健康产生不良影响。
- 肠促胰素尤其是GLP-1在肠-肾信号中起重要作用。
- 该生理学有助于解释胃肠道疾病与IgA肾病的联系,以及炎症性肠病的肾脏表现。
- CKD和终末期肾病增加胃肠道疾病风险并使其管理复杂化,CKD治疗可影响胃肠道症状。
临床怎么用
- 临床应认识肠-肾轴的双向交互,关注CKD患者的胃肠道症状及胃肠道疾病患者的肾脏表现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The kidney and gastrointestinal (GI) tract are closely linked through a bidirectional system involving complex interactions called the gut-kidney axis. Within this system, alterations in the gut microbiome can promote progression of chronic kidney disease (CKD) while uremic toxins from advanced kidney dysfunction can adversely affect intestinal health. Incretin hormones, particularly glucagon-like peptide 1 (GLP-1), play an important role in this gut-kidney signaling and will be explored here. We also examine how this physiology helps explain the connection between GI illness and IgA nephropathy, along with the kidney manifestations seen in inflammatory bowel disease. Furthermore, we will review how CKD and end-stage kidney disease increase the risk of GI disease and complicate its management, and how CKD therapies affect GI symptoms. In this AJKD Core Curriculum, we use a case-based format to illustrate the intricate interplay between the kidneys and the GI tract.
引用
- Stevens, Salani. The Crossroads Between the Kidney and Gastrointestinal Disorders: Core Curriculum 2026. Am J Kidney Dis. 2026. PMID: 42955029. doi:10.1053/j.ajkd.2026.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。